NCT05472337View on ClinicalTrials.gov

Effect of Colchicine on Coronary Reperfusion in Patients With Acute Coronary Syndrome

PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

March 30, 2026

Study Completion Date

June 30, 2026

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Colchicine

Oral colchicine (1 mg loading dose followed by 0.5 mg 1 hour later, administered 6 to 24 hours before angioplasty, followed by 0.5 mg (1 comp.) per day for 6 weeks.

Trial Locations (1)

8330024

RECRUITING

Hospital Clínico Pontificia Universidad Catolica de Chile, Santiago

All Listed Sponsors
collaborator

Fondo Nacional de Desarrollo Científico y Tecnológico, Chile

OTHER_GOV

lead

Pontificia Universidad Catolica de Chile

OTHER